Jamaica vs Maldives: The number of people with susceptibility test result for rifampicin
Jamaica
44
in 2021
Maldives
46
in 2021
Jamaica rank
124th
Maldives rank
123rd
The number of people with susceptibility test result for rifampicin over time
- Jamaica
- Maldives
How they compare
Maldives currently reports 46 against 44 in Jamaica, a difference of 2.
Across all 5 years both countries report, Maldives has been ahead every year.
Jamaica ranks 124th and Maldives ranks 123rd of 155 countries.
Maldives has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Jamaica | Maldives | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 36.67 | 76 | 39.33 | Maldives |
| 2020s | 40.5 | 44.5 | 4 | Maldives |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Jamaica or Maldives?
- Maldives, at 46 against 44 in Jamaica as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Jamaica and Maldives?
- 2, with Maldives ahead.
- How many years of comparable data are there for Jamaica and Maldives?
- 5 years are reported by both, from 2017 to 2021.
- How do Jamaica and Maldives rank globally for the number of people with susceptibility test result for rifampicin?
- Jamaica ranks 124th and Maldives ranks 123rd of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.